ALB and neoplasm: Little in vivo preclinical and clinical research has been performed with radiolabeled MMPs, because no radiolabeled MMP currently has an optimal balance between target affinity, hydrophilicity, and intrinsic albumin affinity, for optimal tumor accumulation and tumor-to-background ratios [83].